Tocilizumab did not reduce hypoxemic respiratory failure or death in hospitalized patients with COVID-19. Sharif S, Rochwerg B. Ann Intern Med 2021 Feb 2. doi: 10.7326/ACPJ202102160.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sharif S, Rochwerg B. Tocilizumab did not reduce hypoxemic respiratory failure or death in hospitalized patients with COVID-19. Ann Intern Med 2021 Feb 2. doi: 10.7326/ACPJ202102160.
PMID: 33524280